Thérapies de Conversion

Reply to: "Is the TAE score a promising prognostic predictor for unresectable hepatocellular carcinoma treated with TACE plus lenvatinib with PD‑1 inhibitors? Further validation should be performed".

Hepatol Int . 2024;18 (5) :1589-1590

Résumé

Tous les articles